tiprankstipranks
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
Holding AMLX?
Track your performance easily

Amylyx Pharmaceuticals Inc (AMLX) Income Statement

526 Followers

Amylyx Pharmaceuticals Inc Income Statement

Last quarter (Q3 2024), Amylyx Pharmaceuticals Inc's total revenue was $416.00K, a decrease of -99.59% from the same quarter last year. In Q3, Amylyx Pharmaceuticals Inc's net income was $-72.70M. See Amylyx Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 196.49M$ 380.79M$ 22.23M$ 0.00$ 0.00
Cost of Revenue
$ 125.77M$ 25.44M$ 2.99M--
Gross Profit
$ 70.71M$ 355.35M$ 19.24M--
Operating Expense
$ 275.58M$ 316.54M$ 220.58M$ 82.69M$ 39.01M
Operating Income
$ -272.14M$ 38.80M$ -201.34M$ -82.69M$ -39.01M
Net Non Operating Interest Income Expense
$ 15.86M$ 16.16M$ 4.29M$ 36.00K$ -2.27M
Other Income Expense
$ -120.00K$ -660.00K$ -551.00K$ -5.28M$ -1.00M
Pretax Income
$ -257.48M$ 54.30M$ -197.60M$ -87.93M$ -42.28M
Tax Provision
$ 1.99M$ 5.03M$ 774.00K--
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -252.09M$ 49.27M$ -198.38M$ -87.93M$ -42.28M
Basic EPS
$ -3.82$ 0.73$ -3.39$ -1.59$ -0.93
Diluted EPS
$ -3.82$ 0.70$ -3.39$ -1.59$ -0.93
Basic Average Shares
$ 271.54M$ 67.23M$ 58.50M$ 55.22M$ 45.55M
Diluted Average Shares
$ 273.19M$ 69.99M$ 58.50M$ 55.22M$ 45.55M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 77.86M$ 341.98M$ 223.57M$ 82.69M$ 39.01M
Net Income From Continuing And Discontinued Operation
$ -259.47M$ 49.27M$ -198.38M$ -87.93M$ -42.28M
Normalized Income
$ -121.10M--$ -87.93M$ -41.01M
Interest Expense
---$ 0.00$ 2.29M
EBIT
$ -267.53M$ 38.80M$ -201.34M$ -87.93M$ -39.99M
EBITDA
$ -264.21M$ 39.89M$ -200.85M$ -87.88M$ -39.99M
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis